Get the Stockscreener App
1.345
1.88%
-0.015
60 Degrees Pharmaceuticals Inc stock is traded at $1.345, with a volume of 7,970.
It is down -1.88% in the last 24 hours and down -6.02% over the past month.
60 Degrees Pharmaceuticals Inc operates as a specialty pharmaceutical company with the goal of using biological science and applied research to develop and commercialize new therapies for the prevention and treatment of infectious diseases. The firm's pipeline products under development cover development programs for COVID-19, fungal, tick-borne, and other viral diseases.
See More
Previous Close:
$1.36
Open:
$1.35
24h Volume:
7,970
Relative Volume:
0.06
Market Cap:
$5.48M
Revenue:
$502.40K
Net Income/Loss:
$-7.91M
P/E Ratio:
-0.1349
EPS:
-9.972
Net Cash Flow:
$-4.32M
1W Performance:
-9.83%
1M Performance:
-6.02%
6M Performance:
-41.47%
1Y Performance:
-65.90%
1-Day Range:
$1.3303
$1.3516
1-Week Range:
$1.3303
$1.48
52-Week Range:
$1.215
$12.45
60 Degrees Pharmaceuticals Inc Stock (SXTP) Company Profile
Name
60 Degrees Pharmaceuticals Inc
Sector
Industry
Phone
202-327-5422
Address
1025 CONNECTICUT AVENUE NW, WASHINGTON
Compare SXTP with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SXTP
60 Degrees Pharmaceuticals Inc
|
1.3345 | 5.58M | 502.40K | -7.91M | -4.32M | -9.972 |
|
VRTX
Vertex Pharmaceuticals Inc
|
423.02 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
634.86 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
435.39 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
826.90 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
181.97 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
60 Degrees Pharmaceuticals Inc Stock (SXTP) Latest News
How geopolitical tensions affect 60 Degrees Pharmaceuticals Inc. Equity Warrant stockEarnings Recap Report & Low Risk Profit Maximizing Plans - newser.com
Will 60 Degrees Pharmaceuticals Inc. Equity Warrant see short term momentumWeekly Earnings Recap & Proven Capital Preservation Tips - newser.com
News impact scoring models applied to 60 Degrees Pharmaceuticals Inc.Dividend Hike & Real-Time Stock Movement Alerts - newser.com
Can 60 Degrees Pharmaceuticals Inc. Equity Warrant stock resist market sell offsTrade Analysis Report & Expert-Curated Trade Recommendations - newser.com
How to forecast 60 Degrees Pharmaceuticals Inc. trends using time seriesAnalyst Downgrade & Safe Entry Zone Identification - newser.com
60 Degrees Pharmaceuticals Inc. Equity Warrant stock daily chart insightsJuly 2025 Trends & AI Powered Trade Plan Recommendations - newser.com
What’s next for 60 Degrees Pharmaceuticals Inc. Equity Warrant stock priceWall Street Watch & Daily Profit Focused Screening - newser.com
Why 60 Degrees Pharmaceuticals Inc. stock is popular among millennialsWeekly Gains Summary & Short-Term Swing Trade Alerts - newser.com
Forecasting 60 Degrees Pharmaceuticals Inc. Equity Warrant price range with options dataCPI Data & Long-Term Growth Plans - newser.com
Developing predictive dashboards with 60 Degrees Pharmaceuticals Inc. Equity Warrant dataWeekly Investment Report & Weekly Watchlist for Hot Stocks - newser.com
Is 60 Degrees Pharmaceuticals Inc. Equity Warrant stock attractive for growth ETFs2025 Major Catalysts & Verified Momentum Stock Alerts - newser.com
Real time alert setup for 60 Degrees Pharmaceuticals Inc. performanceMarket Sentiment Report & Reliable Price Action Trade Plans - newser.com
Why analysts upgrade 60 Degrees Pharmaceuticals Inc. stockJuly 2025 Levels & Expert Verified Movement Alerts - newser.com
Has 60 Degrees Pharmaceuticals Inc. Equity Warrant formed a bullish divergenceTreasury Yields & Fast Entry Momentum Trade Alerts - newser.com
Chart based analysis of 60 Degrees Pharmaceuticals Inc. Equity Warrant trendsWeekly Market Outlook & Intraday High Probability Setup Alerts - newser.com
Will 60 Degrees Pharmaceuticals Inc. stock attract more institutional investorsWeekly Stock Analysis & Weekly Setup with High ROI Potential - newser.com
Can momentum traders help lift 60 Degrees Pharmaceuticals Inc.Earnings Summary Report & Breakout Confirmation Alerts - newser.com
Why 60 Degrees Pharmaceuticals Inc. Equity Warrant stock could benefit from AI revolutionTrade Exit Summary & Risk Controlled Stock Alerts - newser.com
How strong is 60 Degrees Pharmaceuticals Inc. Equity Warrant stock revenue growthWeekly Trade Report & Safe Capital Growth Trade Ideas - newser.com
Predicting 60 Degrees Pharmaceuticals Inc. Equity Warrant trend using moving averagesJuly 2025 Big Picture & AI Powered Buy/Sell Recommendations - newser.com
Is 60 Degrees Pharmaceuticals Inc. Equity Warrant stock affected by interest rate hikesDollar Strength & Weekly Top Performers Watchlists - newser.com
60 Degrees Pharmaceuticals and NDT Pharmaceuticals Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - ACCESS Newswire
What machine learning models say about 60 Degrees Pharmaceuticals Inc.Quarterly Earnings Report & Reliable Volume Spike Trade Alerts - newser.com
Is 60 Degrees Pharmaceuticals Inc. stock oversold or undervaluedMarket Risk Report & Capital Efficiency Focused Ideas - newser.com
Using data models to predict 60 Degrees Pharmaceuticals Inc. stock movementEarnings Risk Summary & Advanced Technical Analysis Signals - newser.com
Institutional scanner results for 60 Degrees Pharmaceuticals Inc. Equity WarrantMarket Weekly Review & Accurate Technical Buy Alerts - newser.com
How 60 Degrees Pharmaceuticals Inc. Equity Warrant stock reacts to global recession fearsJuly 2025 News Drivers & Daily Technical Forecast Reports - newser.com
60 Degrees Pharmaceuticals Inc Stock (SXTP) Financials Data
Revenue
Net Income
Cash Flow
EPS
60 Degrees Pharmaceuticals Inc Stock (SXTP) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| XU CHERYL | Director |
Dec 13 '24 |
Buy |
1.56 |
6,000 |
9,375 |
52,078 |
| XU CHERYL | Director |
Dec 12 '24 |
Buy |
1.82 |
5,000 |
9,125 |
46,078 |
| XU CHERYL | Director |
Dec 16 '24 |
Buy |
1.45 |
2,000 |
2,900 |
54,078 |
| DOW GEOFFREY S | President and CEO |
Dec 09 '24 |
Buy |
1.27 |
35,823 |
45,563 |
94,580 |
| DOW GEOFFREY S | President and CEO |
Dec 06 '24 |
Buy |
1.20 |
20,579 |
24,672 |
58,757 |
| DOW GEOFFREY S | President and CEO |
Dec 05 '24 |
Buy |
1.11 |
17,549 |
19,520 |
38,178 |
| DOW GEOFFREY S | President and CEO |
Nov 21 '24 |
Buy |
0.91 |
3,500 |
3,195 |
20,629 |
| DOW GEOFFREY S | President and CEO |
Nov 19 '24 |
Buy |
0.90 |
2,500 |
2,248 |
16,129 |
| DOW GEOFFREY S | President and CEO |
Nov 20 '24 |
Buy |
0.92 |
1,000 |
924 |
17,129 |
0.68%
0.96%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):